Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

708

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Acne Vulgaris
Interventions
DRUG

Clindamycin Phosphate / Benzoyl Peroxide Gel

Dosage form: topical gel Dosage: One pea-sized amount will be applied onto six areas of the face (chin, left cheek, right cheek, nose, left forehead, right forehead), avoiding the eyes, lips and mucous membranes.

DRUG

Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%

Dosage form: topical gel Dosage: One pea-sized amount will be applied onto six areas of the face (chin, left cheek, right cheek, nose, left forehead, right forehead), avoiding the eyes, lips and mucous membranes.

DRUG

Placebo (Vehicle Gel)

Dosage form: topical gel Dosage: One pea-sized amount will be applied onto six areas of the face (chin, left cheek, right cheek, nose, left forehead, right forehead), avoiding the eyes, lips and mucous membranes.

All Listed Sponsors
lead

Watson Laboratories, Inc.

INDUSTRY

NCT01788384 - Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris | Biotech Hunter | Biotech Hunter